The fascinating complexities of steroid-binding enzymes

Current Opinion in Structural Biology

Volumn 6, Issue 6, 1996, Pages 813-823

  Duax, William L ^a   Griffin, Jane F ^a   Ghosh, Debashis ^b  

^a HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA(OR 20BETA) HYDROXYSTEROID DEHYDROGENASE; ALCOHOL DERIVATIVE; ENZYME; ENZYME INHIBITOR; OXIDOREDUCTASE; PROSTAGLANDIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID; STEROID BINDING PROTEIN; SUGAR; TESTOSTERONE 17BETA DEHYDROGENASE;

AMINO ACID COMPOSITION; BINDING SITE; BLOOD PRESSURE REGULATION; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME CONFORMATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; FERTILITY; GLYCYRRHIZA; GROWTH; HORMONAL REGULATION; PRIORITY JOURNAL; REVIEW; STEROID BINDING; STEROID METABOLISM;

GLYCYRRHIZA;

EID: 0030458319     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(96)80012-1     Document Type: Article

References (52)

1. Duax WL, Gntfin JF: The structure and receptor binding of steroid hormones. In Advances in Drug Research. Edited by Testa B. New York: Academic Press; 1989:115-138.
2. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1 988, 240:889-895.
3. Westbrook EM, Piro OE, Sigler PB: The 6 ̀crystal structure of A5-3-ketosteroid isomerase. J Bio! Chem 1984, 259:9096-9103.
4. Oh BH, Kim SW, Ryu SE, Kim SS, Yoon M K, Choi KY: Crystallization and preliminary X-ray cristallographie studies of ketosteroid isomerase from Pseudomonas putids biotype B. Proteins 1996, 24:514-515.
5. Vrislink A, Lloyd LF, Blow DM: Crystal structure of cholesterol oxidase from Brevibacterium slerolicum refined at 1.8 A resolution. J Mo! Biol 1 991, 219:533-554.
6. Li J, Vnelmk A, Brick P, Blow DM: Crystal structure of cholesterol oxidase completed with a steroid substrate: implications for flavin adenine dinucleotide dependent alcohol oxidase. Biochemistry 1993, 32:11507-11515.
7. Ghosh D, Wawrzak S, Pletnav VZ, Li N, Kaiser R, Pangborn W, Jornvall H, Erman M, Duax WL: Structure of uncomplexed and linoleate-bound Candida cylindracea cholesterol esterase. Structuie 1995, 3:279-288.
8. Jdrnvall H, Persson B, Krook M, Atrian S, Gonzalez Duarte JJ, Ghosh D: Short-chain dehydrogenase/reductases (SDR). Biochemistry 1995, 34:6003-6013. The authors present a comprehensive sequence analysis and correlation with (unction for the SDR family of proteins.
9. Birktoft JJ, Banaszak U: Structure-function relationships among nicotinamide-adenine dinucleotide dependent oxidoreductases. In Pepf/rfe and Protein Reviews, vol 4. Edited by Hearn MTW. New York: Marcel Dekker Inc; 1984:1-44.
10. Watson HC. Banaszak LJ: Structure of glyceraldehyde-3phosphate dehydrogenase. Nature 1964, 204:918-920
11. Adams MJ, Ford GC, Koekock R, Lentz R) Jr, McPherson A Jr, Rossmann MG, Smiley IE: Structure of lactate dehydrogenase at 2.8 Aresolution. Nature 1970, 227:1098-1103.
12. 2. Hill E, Tsernoglau D, Webb L. Banaszak LI: Polypeptide conformation of cytoplasmic mal ate dehydrogenase from an electron density map at 3.DA resolution. J Mo! Biol 197?, 72:577-589,
13. 3. Scrutton NS, Berry A, Perham RN: Redesign of the coenzyme specificity of a dehydrogenase by protein engineering. Nature 1990, 343:38-43.
14. Ghosh D, Wawrzak Z, Weeks CM, Duax WL, Erman M: The refined three-dimensional structure of 3a,20-hydroxysteroid dehydrogenase and possible roles of the residues conserved in short-chain dehydrogenases. Structure 1994, 2:629-640.
15. Varughese Kl, Skinner MM. Whiteley JW, Matthews DA, Xuong NH: Crystal structure of rat liver dihydropteridine re du cta se Proc Natl Acad Scr USA 1992, 89:6080-6084.
16. Tanaka N, Nonaka I Nakanishi M, Deyashiki Y, Hara A, Mitsui Y: Crystal structure of the ternary complex of mouse lung carbonyl reductase at 1.8A resolution: the structural origin of coenzyme specificity in the short-chain dehydrogenase/reductase family. Structure 1996, 4:33-45. The first X-ray structure determination ol an SDR enzyme completed with NADPH is presented, revealing strong electrostatic interactions between quasi conserved residues (Lysl 7 and Arg39) and the 2′ phosphate group of NADPH.
17. 7. Tanaka N, Nonaka T, Yashimoto T, Tsura D, Mitsui Y: Crystal structures of the binary and ternary complexes of 7α-hydroxysteroid dehydrogenase from E, coll. Biochemistry 1996, 35:7715-7730. The X-ray structure determinations of 7a-HSD unequivocally demonstrate the role of the single fully conserved residue in the SDR family, a lyrosme, in the mechanism of action.
18. Ghosh D, Pletnev VZ, Zhu DW, Wawrzak Z, Duax WL, Pangborn W, Lahrie F, Lin SX: Structure of human_estrogenic 17β-hydroxysteroid dehydrogenase at 2.20 Aresolution. Structure 1995, 3:503-513. The first X-ray structure of a human SDR Is presented, with direct bearing on carcinogenesis. This enzyme catalyzes the reduction of the weak estrogen, estrone, to the most potent, estradiol. Excess estradiol is thought to stimulate the so-called 'hormone dependent' breast tumors.
19. Sweet F, S air an t BR; Bifunctional enzyme activity at the same active site: study of 3u and 20β activity by affinity alkylation of 3o;20β-hydroxysteroid dehydrogenase with 17-(bromoacetoxy)steroids. Biochemistry 1980, 19:978-986.
20. Swindells MB: Loopy similarities. Nat Struct Biol 1994, 1:421-422.
21. Declercq JP, Germain G, Van Meerssche M: 17o,20β-dihydroxy4-pregnene-3,11,20-trione CjihgOg. Crystal Struct Commun 1972, 1:13-15.
22. Girerd RJ, Rassasrt CL, DiPasquale G, Kroc RL: Endocrine involvement in licorice hypertension. Am J Physio! 1958, 194:241-245.
23. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramierz LC, Rauh W, Rosler A, Bradlow HL, New Ml: A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979, 49:757.
24. Tsuganezawa H, Hayashi M, Fujii Y, Yamaji Y, lyori M, Saruta T: Corticosterone increases Na+-K+ ATPase activity in rat corticol collecting ducts with inhibition of 11β-hydroxysteroid dehydrogenase. Rena! Physiol Biochem 1995, 18:66-72. The authors demonstrate the tissue-specific locus of 110-HSD inhibition relevant to hypertension.
25. Kageyama Y, Suzuki H, Saruta T: Role of glucocorticoid in the development of glycyrrhizie acid-induced hypertension. Clin Exp Hyperiens 1994, 16:761-778.
26. New Ml. Oberfield SE, Carey R, Greig F, Ulick S, Levind LS: A genetic defect in cortisol metabolism as the basis for the syndrome of apparent mineralocorticoid excess. In Serono Symposium No. 50, Endocrinology of Hypertension. Edited by Mantero F, Biglieri E, Edwards CRW. London: Academic Press; 1982:85-101.
27. Mondor C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CRW: Licorice inhibits corticosteroid dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology 1989, 125:1046-1053
28. 2B. Rao CV, Riverson A, Kelloff GJ, Reddy BS: Chemoprevention of azoxymethane-induced colon cancer by ascorbylpalmitate, carbenoxolone, dlmethylfumarate and p-methoxyphenol in maie F344 rats. Anticancer Res 1995, 15:1199-1204
29. Ghosh D, Erman M, Pangborn W, Duax WL, Baker ME: Inhibition of Streptomyces hyctrogenans 3o,20β-hydroxysteroid dehydrogenase by licorice-derived compounds and crystallization of an enzyme-cofactor-inhibitor complex. 1 Steroid Biochem Moi Bio! 1992, 42:849-853,
30. Ghosh D, Erman M, Wawrzak Z, Duax WL, Pangborn W: Mechanism of inhibition of 3o,20β-hydroxysteroid dehydrogenase by a licorice-derived steroidai inhibitor. Structure 1994. 2:973-980.
31. Maser E, Bannenberg G: 11 β-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotee carbonyl compounds. Biochem Pharmacol 1994, 47:1805-1812.
32. Stewart PM, Murry BA, Mason Jl: Human kidney 11fJ-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the closed type l isoform. J Clin Endocrino! Metab 1994, 79:480-484.
33. Agarwal AK, Mune T, Wonder C, White PC: Mutations in putative glycosylation sites of rat 11 β-hydroxysteroid dehydrogenase affect enzymatic activity. Biochim Biophys Ada 1995, 1248:70-74. Mutagenesis studies of 11 βHSD indicate that substrate specificity is encoded in the carbonyl end of SDR enzymes.
34. Soro A. Ingram MC, Tonolo G, Gloriose N, Fraser R: Evidence f coexisting changes in 11 β-hydroxysteroid dehydrogenase and 5β-reductase activity in subjects with untreated essential hypertension, Hypertension 1995, 26:67-70. The authors conclude that similarities between markers of essential hypertension, AME and carbenoxolone-induced hypertension suggest a role (or 11 -HSD in common essential hypertension.
35. +-dependent enzyme (carbonyl reductase). FEBS Lett 1993, 2:139-142.
36. Krook M. Ghosh D, Stromberg R, Carlquist M, Jornvall H: Carboxyethyllysine in a protein: native carbonyl reductase/NADP4-dependent prostaglandin dehydrogenase. Proc Natl /lead Sei USA 1 993, 90:502-506.
37. Baker ME: Evolution of enzymatic regulation of prostaglandin action: novel connections to regulation of human sex and adrenal function, antibiotic synthesis and nitrogen fixation. Prostsglsndins 1991, 42:391-410.
38. Peura DA: Helicobacter pylori and ulcerogenesis. Am J Med 1996, 100:19-25,
39. Dickson RB, Lippman ME: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endociinol Rev 19B7, 8:29-43.
40. Horwitz KB, McGuire WL: Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J Bio! Chem 1987, 253:8185-8191.
41. Anderson S: 17-Hydroxysteroid dehydrogenase: isoenzymes and mutations. J Endocrinol 1995, 14B:197-300. The author presents an excellent comparative analysis of tissue, substrate and colactor specificity of isoenzymes o( 1 7-HSD.
42. Labrie C. Martel C. Dufour JM, Levesque C, Merand Y, Labrie f": Novel compounds inhibit estrogen formation and action. Cancer Res 1992, 52:510-615.
43. Puranen TJ, Pautanen MH, Peltoketo HE, Vihko PT, Vihko RK: Site-directed mutagenesis of the putative active site of human 17(3-hydroxysteroid dehydrogenase type I. Biochsm J 1994, 304:289-293.
44. Lm S-X, Zhu D-W, Azzi A, Campbell RL, Breton R, Labrie F, Ghosh D, Pletnev V, Duax WL, Pangborn W: Studies on the three-dimensional structure of estrogenic 17β-hydroxysteroid dehydrogenase. J Endocrinol Suppl 1996, 150:13-20.
45. Ribos-de-Pouplona L, Fothergall-Gelmore LA: The active site architecture of a short chain dehydrogenase defined by sitedirected mutagenesis and structure-modeling. Biochemistry 1994,33:7047-7055.
46. Rafferty JB, Simon JW, Baldock C, Artymiuk PJ, Baker PJ, Stuitje AR, Slabas AR, Rice DW: Common themes in redox chemistry emerge from the X-ray structure of oilseed rape (Brassies napus) enoyl acyl carrier protein reductase. Structure 1 995, 3:927-938. The X-ray determination of enoyl acyl carrier protein reductase showed for the first time that a member of the SDR family could function without the YXXXK sequence. In this protein an analogous position of the catalytic residues tyrosine and lipase, relative to the colactor location, is achieved in a novel fashion.
47. Dessen A, Ouomard A, Blanchard JS, Jacobs WR Jr, Sacchettim C: Crystal structure and function of the isoniazid target of Mycobacisrium tuberculosis. Science 1995, 267:30-41. This paper presents an X ray structure which led to the realization that an enzyme critical to successful treatment of tuberculosis is a member of the SDR family.
48. Bohren KW, Wermuth B, Harrison D, Ringe D, Petsko GA, Gabbay KH: Expression, crystallization and preliminary cristallographie analysis of human carbonyl reductase. J Mol Biol 1994, 244:659-664.
49. Bohren KM, Bullock B, Wermuth B, Gabbay KH: The aldo-keto reductase superfamily cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Bio! Chem 1989, 264:9547-9551.
50. Hoog SS, Pawlowski JE, Alzari PM, Penning TM, Lewis W: Three-dimensional structures of rat liver 3ahydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo keto reductase superfamily. Proc Nat! Acad Sei USA 1994, 91:2517-2521.
51. Bennett MJ, Schlegel BP, Jan JM, Penning TM, Lewis M: Structure of 3a-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+. Biochemtslfy 1996, 36:in press.
52. Penning TM, Pawlowski JE, Schlegel BP, Jez JM, Lin H-K, Hoog SS, Bennett Mj, Lewis M: Mammalian 3a-hydroxy steroid dehydrogenase. Steroids 1996, 61:508-523.